RETINOIC ACID RECEPTOR BETA-2 (RAR-BETA-2) NULL MUTANT MICE APPEAR NORMAL

Citation
C. Mendelsohn et al., RETINOIC ACID RECEPTOR BETA-2 (RAR-BETA-2) NULL MUTANT MICE APPEAR NORMAL, Developmental biology, 166(1), 1994, pp. 246-258
Citations number
79
Categorie Soggetti
Developmental Biology",Biology
Journal title
ISSN journal
00121606
Volume
166
Issue
1
Year of publication
1994
Pages
246 - 258
Database
ISI
SICI code
0012-1606(1994)166:1<246:RARB(N>2.0.ZU;2-A
Abstract
Vertebrates are highly sensitive to both retinoic acid (RA) deficiency and excess. The RA signal is thought to be transduced by nuclear rece ptors (the RAR and RXR families) which activate the expression of targ et genes via cis-acting transcriptional enhancer elements. Each of the three RAR genes, RAR alpha, RAR beta, and RAR gamma, gives rise to se veral isoforms by differential usage of two promoters and alternative splicing. RAR beta 2 is the most abundant of the four RAR beta isoform s, and its transcription is spatially and temporally restricted in dev eloping embryos, suggesting that it might perform specific functions. Furthermore, RAR beta 2 expression can be induced via a retinoic acid response element located in its promoter region. This RA effect is par ticularly interesting since under conditions of RA excess, RAR beta 2 promoter activity and transcript accumulation are induced in regions o f developing embryos in which malformations subsequently appear, such as the craniofacial region, the hindbrain, and the limbs. These findin gs have led to the suggestion that the RAR beta 2 isoform might mediat e some of the teratogenic effects of RA. In this study, we have elimin ated RAR beta 2 expression by targeted gene disruption. RAR beta 2 nul l mutants exhibit an apparently normal phenotype, indicating that othe r RARs must compensate for RAR beta 2 sufficiently well to allow norma l prenatal and postnatal development to proceed. By challenging RAR be ta 2 null embryos with teratogenic doses of RA, we have also directly addressed the question of whether RAR beta 2 is required for mediating RA-induced malformations. (C) 1994 Academic Press, Inc.